As of 2025-06-02, the Fair Value of Thalys Medical Technology Group Inc (603716.SS) is -5.93 CNY. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 12.54 CNY, the upside of Thalys Medical Technology Group Inc is -147.32%.
With the market price of 12.54 CNY and our fair value calculation, Thalys Medical Technology Group Inc (603716.SS) is not a good investment. Investing in 603716.SS stocks now will result in a potential loss of 147.32%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 57.60 | -49.51 | -154.42 | -158.57 | -209.24 | -102.83 |
| YoY growth | -47.83% | -185.95% | -211.92% | -2.69% | -31.95% | -96.07% |
| Market Cap (mil) | 2,395.39 |
| P/E | |
| Forward P/E |
| EPS | -1.19 |
| Avg earnings growth rate | -96.07% |
| TTM earnings | -226.72 |